Lipopolysaccharide-induced interleukin-6 production is controlled by glycogen synthase kinase-3 and STAT3 in the brain.
Lipopolysaccharide-induced interleukin-6 production is controlled by glycogen synthase kinase-3 and STAT3 in the brain.
复制标题
脑内脂多糖诱导的白介素-6的产生是由糖原合成酶激酶3和STAT3控制的。
DOI:
10.1186/1742-2094-6-9
复制
发表时间:
2009-03-11
影响因子:
9.3
通讯作者:
Jope RS
中科院分区:
文献类型:
--
作者:
Beurel E;Jope RS
Septic shock is a prevalent condition that, when not lethal, often causes disturbances in cognition, mood, and behavior, particularly due to central actions of the inflammatory cytokine interleukin-6 (IL-6). To identify potential targets to control brain IL-6, we tested if IL-6 produced by glia is regulated by signal transducer and activator of transcription-3 (STAT3) and glycogen synthase kinase-3 (GSK3). Lipopolysaccharide (LPS) was used to induce inflammatory responses in mice or cultured primary glia. IL-6 was measured by ELISA and other inflammatory molecules were measured using an array. Mouse brain IL-6 levels increased after central, as well as peripheral, LPS administration, consistent with glia producing a portion of brain IL-6. STAT3 in the brain was activated after peripheral or central LPS administration, and in LPS-stimulated cultured primary glia. Inhibition of STAT3 expression, function, or activation reduced by ~80% IL-6 production by primary glia, demonstrating the dependence on active STAT3. GSK3 promotes STAT3 activation, and array analysis of inflammatory molecules produced by LPS-stimulated primary glia demonstrated that IL-6 was the cytokine most diminished (>90%) by GSK3 inhibition. Inhibition of GSK3, and knockdown of GSK3β, not GSK3α, greatly inhibited IL-6 production by LPS-stimulated primary glia. Conversely, expression of active STAT3 and active GSK3 promoted IL-6 production. In vivo inhibition of GSK3 reduced serum and brain IL-6 levels, brain STAT3 activation, and GFAP upregulation following LPS administration. STAT3 and GSK3 cooperatively promote neuroinflammation, providing novel targets for anti-inflammatory intervention.
登录
查看更多内容
DOI:
10.1083/jcb.85.3.890
发表时间:
1980-06
期刊:
The Journal of cell biology
影响因子:
--
作者:
McCarthy KD;de Vellis J
通讯作者:
de Vellis J
DOI:
10.1084/jem.20030077
发表时间:
2003-11-17
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Kano A;Wolfgang MJ;Gao Q;Jacoby J;Chai GX;Hansen W;Iwamoto Y;Pober JS;Flavell RA;Fu XY
通讯作者:
Fu XY
影响因子:
56.9
作者:
Bonni, A;Sun, Y;Greenberg, ME
通讯作者:
Greenberg, ME
影响因子:
4.8
作者:
Beurel, Eleonore;Jope, Richard S.
通讯作者:
Jope, Richard S.
DOI:
10.1186/cc5783
发表时间:
2007
期刊:
Critical care (London, England)
影响因子:
--
作者:
Bozza FA;Salluh JI;Japiassu AM;Soares M;Assis EF;Gomes RN;Bozza MT;Castro-Faria-Neto HC;Bozza PT
通讯作者:
Bozza PT